Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
sumatriptan succinate, Quantity: 139.98 mg
Pharmacor Pty Ltd
sumatriptan succinate
Tablet, film coated
Excipient Ingredients: lactose monohydrate; hypromellose; croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide
Oral
2 tablets
(S4) Prescription Only Medicine
Pharmacor Sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine
Visual Identification: White to off-white, capsule shaped, biconvex, film coated tablet plain on both sides.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2010-03-26
PHARMACOR SUMATRIPTAN _Sumatriptan succinate _ _ _ _ _ _ _ _ _ CONSUMER MEDICINE INFORMATION Pharmacor Sumatriptan (V 02) Page 1 of 3 WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start taking Pharmacor Sumatriptan. This leaflet answers some common questions about Pharmacor Sumatriptan. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the expected benefits of you taking Pharmacor Sumatriptan against the risks this medicine could have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ARE PHARMACOR SUMATRIPTAN USED FOR? Pharmacor Sumatriptan contain the active ingredient sumatriptan succinate. This medicine belongs to a group of drugs called serotonin agonists. Pharmacor Sumatriptan are used to relieve a migraine attack. They should not be used to prevent migraine attacks from occurring. Pharmacor Sumatriptan may be used for migraine headaches with or without what is known as 'aura'. It is thought that migraine headache is due to widening of certain blood vessels in the head. Pharmacor Sumatriptan work by making those vessels normal again and ease the symptoms of migraine. Your Pharmacor Sumatriptan do not work in other types of headache which are not a migraine. Pharmacor Sumatriptan is not addictive. BEFORE YOU TAKE PHARMACOR SUMATRIPTAN _DO NOT TAKE IF: _ You must not take Pharmacor Sumatriptan if: • YOU HAVE EVER HAD AN ALLERGIC REACTION TO SUMATRIPTAN SUCCINATE (SEE "SIDE-EFFECTS") OR ANY OF THE INGREDIENTS LISTED TOWARD THE END OF THIS LEAFLET. (SEE "INGREDIENTS"). • YOU HAVE OR HAVE HAD: - Heart disease or heart attack. - Shortness of breath, pain or tightness in the chest, jaw or upper arm. - Peripheral vascular disease (pain in the back of the legs) or are prone to cold, tingling or numb hands and feet. - Prinzmetal's angina (an un Lue koko asiakirja
Pharmacor Sumatriptan (V 03) Page 1 of 14 AUSTRALIAN PRODUCT INFORMATION PHARMACOR SUMATRIPTAN (SUMATRIPTAN SUCCINATE) TABLETS 1 NAME OF THE MEDICINE Sumatriptan succinate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains Sumatriptan succinate equivalent to 50 mg Sumatriptan. Each film-coated tablet contains Sumatriptan succinate equivalent to 100 mg Sumatriptan. List of excipients with known effects: sugars as lactose. For the full list of excipients, SEE SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Pharmacor Sumatriptan is available in two strengths, 50 mg and 100 mg. PHARMACOR SUMATRIPTAN 50 Pink coloured, capsule shaped biconvex film coated tablets, plain on both sides. PHARMACOR SUMATRIPTAN 100 White to off-white coloured, capsule shaped biconvex film coated tablets, plain on both sides. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Pharmacor Sumatriptan are indicated for the acute relief of migraine attacks with or without aura. There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine. 4.2 DOSE AND METHOD OF ADMINISTRATION Pharmacor Sumatriptan are indicated for the acute intermittent relief of both migraine and cluster headache. It should not be used prophylactically. Ergotamine or ergotamine derivatives and sumatriptan should not be administered concurrently (see SECTION 4.3 CONTRAINDICATIONS). MIGRAINE It is recommended to start the treatment at the first sign of a migraine headache or associated symptoms such as nausea, vomiting or photophobia. The efficacy of Pharmacor Sumatriptan is independent of the duration of the attack when starting treatment. Pharmacor Sumatriptan (V 03) Page 2 of 14 Administration during a migraine aura prior to other symptoms occurring may not prevent the development of a headache. If a patient does not respond to the first dose of Pharmacor Sumatriptan, a second dose should not be taken for the same attack. Pharmacor Sumatriptan may be used for subsequent attacks. TABLETS Th Lue koko asiakirja